• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PTX

PRESCIENT THERAPEUTICS LIMITED - Charts / Financials

5.00% ! 8.4¢
Market Cap $84.12M  !

Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing... Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cell therapies.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 23/01/2026 (20 minute delay) ?
Day
Open 8.2¢   Day High 8.4¢   Day Low 7.9¢
Daily Volume 284993
Bids   Sellers
Number Price Volume   Number Price Volume
0 8.2¢ 10000   0 8.6¢ 11500

Directors & Senior Management

Dr. Allen Ebens Non-Executive Director
Prof. Andrew Tsourkas Member of Scientific Advisory Board
Dr. Donald M. O’Rourke Member of Scientific Advisory Board
Dr. Ellen Gwen Feigal Independent & Non- Executive Director
Mr. Farhad Ravandi Member of Scientific Advisory Board
Dr. Gavin James Shepherd Independent Non-Executive Director
Prof. Henry Miles Prince Member of Scientific Advisory Board
Dr. James A. Campbell Independent Non-Executive Chairman
Mr. James McDonnell Chief Executive Officer
Prof. Jeffrey Lancet Member of Scientific Advisory Board
Prof. Joshua Douglas Member of Scientific Advisory Board
Dr. Marco L. Davila Member of Scientific Advisory Board
Dr. Marissa Lim Chief Medical Officer
Ms. Melanie Farris Independent Non-Executive Director
Ms. Melanie Jaye Leydin CFO & Company Secretary
Prof. Phillip Darcy Member of Scientific Advisory Board
Dr. Rebecca Tunstall Chief Operating Officer
Prof. Reinhard Dummer Member of Clinical Advisory Board
Dr. Rodney Daniel Sinclair Chairman of Clinical Advisory Board
Dr. Thomas Prebet Member of Scientific Advisory Board

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.4¢
Change
0.004(5.00%)
Mkt cap ! $84.12M
Open High Low Volume
8.2¢ 8.4¢ 7.9¢ 284.9K

Buyers (Bids)

Vol. Price($)
10000 8.2¢
 

Sellers (Offers)

Price($) Vol.
8.6¢ 11500
Last trade - 15.59pm 23/01/2026 (20 minute delay) ?
Capital Compass
AGE
AGE
ALLIGATOR ENERGY LIMITED
Dr Andrea Marsland-Smith, CEO
Dr Andrea Marsland-Smith
CEO
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.